Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk
Shantha Biologics, a Sanofi company based in Hyderabad, has collaborated with global healthcare major Novo Nordisk to provide formulation and cartridge fill-finish services for its insulin products. This partnership leverages India's capabilities in biopharmaceutical contract manufacturing to address the rising burden of diabetes in the country. It highlights India's growing stature as a reliable, high-tech hub for complex pharmaceutical manufacturing and clinical supply chains.
Read source at The Hindu — National →Mains Practice Question
While India has established itself as the 'pharmacy of the world' in generic medicine, transitioning to a global hub for advanced biopharmaceuticals requires addressing deep structural and technological bottlenecks. Analyze the role of international collaborations and Contract Development and Manufacturing Organizations (CDMOs) in driving this transition.
150 words
Practice this in the exam hall →Prelims Practice MCQ
In the context of the pharmaceutical and biotechnology industries, the term 'Fill-Finish' refers to which of the following?
- A.The final stage of manufacturing where a drug is sterile-filled into its primary packaging, such as vials or cartridges, and prepared for distribution.
- B.The post-marketing surveillance phase of a newly approved vaccine to monitor long-term efficacy.
- C.The process of extracting active pharmaceutical ingredients (APIs) from natural botanical sources.
- D.The chemical synthesis stage where molecules are designed using computer-aided drug design (CADD).
Fill-finish is a critical final stage in the pharmaceutical product formulation process. It involves filling the active medicine/biologic under sterile (aseptic) conditions into delivery systems like syringes, vials, or cartridges, followed by final sealing and packaging. It requires highly specialized technological infrastructure.
Practice more MCQs like this →